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Intense research has started a new age of cancer treatment for the duration of the last decade, that of molecular therapeutics. Promising preclinical studies have prompted the expansion of clinical trials testing molecules, such as the epidermal growth factor receptor (EGFR) with conventional cytotoxic therapy. 3 The EGFR has a significant role in the differentiation and morphogenesis of numerous organs and proliferation and continued existence of mammalian cells. 4 The EGFR is a proto-oncogene, which if activated at the cell surface by transforming growth factor-α serves to advance cellular proliferation. 4 It is a transmembrane receptor expressed in an array of human tumors of epithelial origin; higher expressions of EGFR are seen in 80% of squamous cell carcinomas (SCCs), which explains that an unrestrained growth may be aided by abnormal EGFR expression. 4 The higher expressions of EGFR have been seen to be of prognostic value in head and neck SCC (HNSCC). 5, 6 This study may help in indicating that EGFR expressions correlate with the severity of OSCC, and it is also possible that the immunohistochemical (IHC) demonstration of these markers may serve to be a useful prognostic tool for a more precise clinical outcome of OSCC.
MatERIalS aND MEtHODS
A total of 50 cases of OSCC were evaluated immunohistochemically for EGFR expression. Normal buccal mucosa has been taken as a control for EGFR.
Inclusion Criteria
Formalin-fixed paraffin-embedded blocks with adequate tissue size (a minimum of 4-5 mm of lesional tissue) for sectioning and IHC staining with representative histological features.
Exclusion Criteria
The tissue and blocks without representative area of any grade of SCC were excluded.
About 4 µm sections were taken, and EGFR was detected by IHC staining using the clone EP38Y (Thermo Scientific rabbit monoclonal antibody #RM-2111-R7, 7 mL). All instances of OSCCs were subjected to histopathological evaluation and sorted as well-differentiated SCC (WDSCC), moderately differentiated SCC (MDSCC), and poorly differentiated SCC (PDSCC) as per Broder's classification of SCC.
aNalYSIS OF IMUNOHIStOCHEMICal StaINING
Positive immunoreactivity was pointed out by the appearance of brown color as the final result at the antigen target spot. The nonpositive control tissue exhibited lack of staining. Tissue sections of normal oral epithelium were taken as positive control for EGFR. The evaluation of study cases was done subsequently in a similar way, and they were graded as positive or negative. The positive results were assessed further for intensity of staining. The presence of brown-colored end product at the site of target antigen was taken as immunohistochemically positive and the negative control tissue demonstrated absence of staining. Presence of immunostaining in the cell membrane of various layers of epithelium was evaluated in randomized six fields/intensity of positively stained cells as percentage expression at ×40 and graded as 0 (under 10% positively stained cells), 1+ (10-25% positively stained cells: Weak expression), 2+ (25-50% positively stained cells: Mild-to-moderate expression), 3+ (50-75% positive cells: Moderate-to-strong expression) ( Table 1) .
Although judging the depth of staining was looked upon as biased, care was taken to decrease the bias by three autonomous investigators (two other investigators who were senior faculty associates in the branch), which demonstrated intensely positive staining in EGFR.
Statistical Methods
The EGFR expression in different grades of OSCC is compared by using the Pearson correlation test and Student's t-test. Mann-Whitney and the Kruskal-Wallis tests were employed for comparison of continuous variables.
RESUltS
The gender distribution of the cases was, male:female ratio being 2.1:1 (34:16). In males, 19 (55%) cases out of 34 were diagnosed as WDSCC, 12 (35.5%) cases out of 34 as PDSCC, and 3 (8.8%) cases out of 34 as MDSCC. In females, 12 (75%) cases out of 16 were diagnosed as WDSCC, 3 (18.8%) as MDSCC, and 1 (6.2%) as PDSCC ( Table 2) .
A total of 32 cases (64%) showed positivity for EGFR, of which 18 (58%) were WDSCC, 4 (66%) cases were MDSCC, and 10 (76%) were PDSCC. Out of the 18 cases of WDSCC that showed positivity for EGFR, 11 (35.5%) showed mild expression and 7 (22.5%) showed moderate expression. Of the 4 cases of MDSCC showing positivity for EGFR, 1 showed mild expression, 2 showed moderate expression, and 1 showed intense expression. Of the 10 cases of PDSCC, 5 showed moderate expression and 5 showed intense expression; p values obtained for EGFR was 0.814, which was nonsignificant (Graph 1, Figs 1 to 4) .
DISCUSSION
A lot of work is currently focused on the recognition of superior biological and clinical factors that can serve as a predictive and prognostic marker. The perception of the biological initiation of tumor development and its progression in the oral cavity has enhanced as a result of the Graph 1: Expression of EGFR in different grades of OSCC current advances in fundamental research and genomics. As a result, an array of molecular tumor markers evaluated in the laboratory have been recognized in HNSCC for their potential to predict disease result or response to treatment in patients. According to our present study, we expect to gather further proficiency to either anticipate patients at risk for disease development after standard therapy or identify those who can gain from postoperative radiotherapy and those with radioresistant tumors.
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Our study showed moderate-to-intense EGFRexpression in more than 40% of the cases (p-value = 0.814), including all grades of SCC. The status of the lymph node was not recorded for our study. As the grade of the SCC increased, i.e., from WDSCC to PDSCC, the intensity of EGFR increased. It can be summarized that somewhere the expression of EGFR is related to the grade of SCC.
Xia et al, 8 after studying different family members of the EGFR, conclude that there are no significant associations between the expression levels of the EGFR family members and the sex, and histological grade (p > 0.05) except that EGFR expression level is significantly associated with age (p < 0.001). Our study included 23 cases of WDSCC that were recorded from the below 50 age group with positive EGFR expression as compared with only 4 cases of PDSCC in this age group; about 9 of the 13 PDSCC cases, however, recorded from the above 50 age group support the above-mentioned fact. On the contrary, according to a study conducted by Diniz-Freitas et al, 9 none of the factors, such as age, sex, tumor size and depth, intraoral site, lymph node metastasis, clinical phase, and histological demarcation was concurrent with EFGR expression.
A positive association with cell proliferation and a prognostic significance regarding overall and diseasefree survival was found by Temam et al. 10 However, it could not be confirmed by Gröbe et al 11 who studied IHC expression of the EGFR in OSCC. 
CONClUSION
This study can help in indicating that EGFR expression correlates with the severity of OSCC, and the IHC demonstration of these markers can serve to be a useful prognostic tool for a more precise clinical outcome of OSCC. Increased expression of EGFR in PDSCC may suggest its positive role in the proliferation and differentiation of tumor cells and prognostic significance regarding overall and disease-free survival. However, along with statistically nonsignificant outcome, the sample size taken was also very limited. Hence, further studies with a larger sample size are required to reach a firm conclusion.
